North America Patient Care Monitoring Device Market Industry: Market Size & Forecast 2026

The North America patient care monitoring device market represents the regional subset of a broader global patient monitoring industry, capturing roughly 35-43% of worldwide revenue depending on scope. In 2025 the regional market is valued at approximately $22.7 billion, making it the largest geographic segment by revenue. Growth is projected at a compound annual rate near 7.7%, with public statistics agencies tracking underlying inputs like device registrations and trade flows rather than publishing consolidated market totals.

• •North America accounts for the largest share of the global patient monitoring market, roughly 35-43%.
• •Market size in the region is around $22.7 billion in 2025, with a forecast CAGR near 7.7%.
• •Aggregate market figures are industry estimates; official agencies report device approvals and trade rather than total market value.

Aging demographics and the growing burden of chronic conditions such as cardiovascular disease, diabetes, and respiratory illness are expanding the pool of patients who need continuous monitoring. Reimbursement expansion for remote physiologic monitoring and the broader push to reduce hospital admissions are making home-based devices economically attractive for providers and payers. Hospital investment in wireless infrastructure, EHR integration, and early-warning analytics is also pulling capital into multi-parameter bedside and wearable systems.

• •Aging population and rising chronic disease prevalence are increasing the base of monitored patients.
• •Favorable reimbursement for remote physiologic monitoring is accelerating adoption of home-based devices.
• •Acute-care demand for continuous, EHR-connected surveillance is driving replacement of older bedside monitors.

The market is commonly segmented by product (bedside multi-parameter monitors, wearable and remote devices, neonatal and specialty monitors), by end user (hospitals, ambulatory and clinics, and home care), and by acuity level (critical care vs. general ward). Within North America, the United States is the dominant country, with U.S. patient monitoring estimates ranging from roughly $10 billion (equipment-only scope) up to about $19.8 billion (broader care-monitoring scope), while Canada and Mexico contribute additional regional volume. Remote patient monitoring is one of the fastest-growing sub-segments, with some estimates placing the North American RPM segment near $28.8 billion in 2025.

• •Hospitals remain the largest end-user segment, but home care is the fastest-growing user setting.
• •The United States accounts for the bulk of regional revenue, with Canada and Mexico adding the rest.
• •Multi-parameter bedside monitors and remote/wearable devices are the two largest product groups.

What are the recent trends and outlook?

The most pronounced trend is the migration of monitoring from the hospital into the home, supported by connected wearables, cellular gateways, and cloud analytics. AI and predictive algorithms are being layered onto device streams to flag deterioration earlier, particularly in ICU and post-acute settings. Cybersecurity, interoperability standards, and clearer reimbursement pathways are expected to shape which vendors scale fastest through the remainder of the decade.

• •Care is shifting from inpatient monitoring to home and ambulatory RPM, the fastest-growing segment.
• •AI-driven early-warning analytics are becoming a key differentiator alongside device hardware.
• •Interoperability, cybersecurity, and reimbursement policy will heavily influence vendor growth through 2030.